1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
2
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar : PubMed/NCBI
|
3
|
Chapoval AI, Ni J, Lau JS, Wilcox RA,
Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K, et al: B7-H3: A
costimulatory molecule for T cell activation and IFN-gamma
production. Nat Immunol. 2:269–274. 2001. View Article : Google Scholar : PubMed/NCBI
|
4
|
Dong C, Nurieva RI and Prasad DV: Immune
regulation by novel costimulatory molecules. Immunol Res. 28:39–48.
2003. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kang FB, Wang L, Jia HC, Li D, Li HJ,
Zhang YG and Sun DX: B7-H3 promotes aggression and invasion of
hepatocellular carcinoma by targeting epithelial-to-mesenchymal
transition via JAK2/STAT3/Slug signaling pathway. Cancer Cell Int.
15:452015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang T, Jiang B, Zou S-T, Liu F and Hua
D: Overexpression of B7-H3 augments anti-apoptosis of colorectal
cancer cells by Jak2-STAT3. World J Gastroenterol. 21:1804–1813.
2015. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kang FB, Wang L, Li D, Zhang YG and Sun
DX: Hepatocellular carcinomas promote tumor-associated macrophage
M2-polarization via increased B7-H3 expression. Oncol Rep.
33:274–282. 2015. View Article : Google Scholar : PubMed/NCBI
|
8
|
Jin Y, Zhang P, Li J, Zhao J, Liu C, Yang
F, Yang D, Gao A, Lin W, Ma X, et al: B7-H3 in combination with
regulatory T cell is associated with tumor progression in primary
human non-small cell lung cancer. Int J Clin Exp Pathol.
8:13987–13995. 2015.PubMed/NCBI
|
9
|
Dai W, Shen G, Qiu J, Zhao X and Gao Q:
Aberrant expression of B7-H3 in gastric adenocarcinoma promotes
cancer cell metastasis. Oncol Rep. 32:2086–2092. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Sun J, Guo YD, Li XN, Zhang YQ, Gu L, Wu
PP, Bai GH and Xiao Y: B7-H3 expression in breast cancer and
upregulation of VEGF through gene silence. Onco Targets Ther.
7:1979–1986. 2014. View Article : Google Scholar : PubMed/NCBI
|
11
|
Yuan H, Wei X, Zhang G, Li C, Zhang X and
Hou J: B7-H3 over expression in prostate cancer promotes tumor cell
progression. J Urol. 186:1093–1099. 2011. View Article : Google Scholar : PubMed/NCBI
|
12
|
Zang X, Sullivan PS, Soslow RA, Waitz R,
Reuter VE, Wilton A, Thaler HT, Arul M, Slovin SF, Wei J, et al:
Tumor associated endothelial expression of B7-H3 predicts survival
in ovarian carcinomas. Mod Pathol. 23:1104–1112. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Zhang W, Wang Y, Wang J, Dong F, Zhu M,
Wan W, Li H, Wu F, Yan X and Ke X: B7-H3 silencing inhibits tumor
progression of mantle cell lymphoma and enhances chemosensitivity.
Int J Oncol. 46:2562–2572. 2015.PubMed/NCBI
|
14
|
Du W, Hong J, Wang YC, Zhang YJ, Wang P,
Su WY, Lin YW, Lu R, Zou WP, Xiong H, et al: Inhibition of
JAK2/STAT3 signalling induces colorectal cancer cell apoptosis via
mitochondrial pathway. J Cell Mol Med. 16:1878–1888. 2012.
View Article : Google Scholar : PubMed/NCBI
|
15
|
Xiong H, Chen ZF, Liang QC, Du W, Chen HM,
Su WY, Chen GQ, Han ZG and Fang JY: Inhibition of DNA
methyltransferase induces G2 cell cycle arrest and apoptosis in
human colorectal cancer cells via inhibition of JAK2/STAT3/STAT5
signalling. J Cell Mol Med. 13:3668–3679. 2009. View Article : Google Scholar : PubMed/NCBI
|
16
|
Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang
QC, Zhang YJ, Lu R, Chen YX and Fang JY: Inhibition of JAK1,
2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces
tumor cell invasion in colorectal cancer cells. Neoplasia.
10:287–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
17
|
Wang Z-S, Zhong M, Bian Y-H, Mu Y-F, Qin
S-L, Yu M-H and Qin J: MicroRNA-187 inhibits tumor growth and
invasion by directly targeting CD276 in colorectal cancer.
Oncotarget. 7:44266–44276. 2016. View Article : Google Scholar : PubMed/NCBI
|
18
|
zur Hausen H: Papillomaviruses and cancer:
From basic studies to clinical application. Nat Rev Cancer.
2:342–350. 2002. View
Article : Google Scholar : PubMed/NCBI
|
19
|
Sica GL, Choi IH, Zhu G, Tamada K, Wang
SD, Tamura H, Chapoval AI, Flies DB, Bajorath J and Chen L: B7-H4,
a molecule of the B7 family, negatively regulates T cell immunity.
Immunity. 18:849–861. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Tringler B, Zhuo S, Pilkington G, Torkko
KC, Singh M, Lucia MS, Heinz DE, Papkoff J and Shroyer KR: B7-h4 is
highly expressed in ductal and lobular breast cancer. Clin Cancer
Res. 11:1842–1848. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Fauci JM, Straughn JM Jr, Ferrone S and
Buchsbaum DJ: A review of B7-H3 and B7-H4 immune molecules and
their role in ovarian cancer. Gynecol Oncol. 127:420–425. 2012.
View Article : Google Scholar : PubMed/NCBI
|
22
|
Liu H, Tekle C, Chen Y-W, Kristian A, Zhao
Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, et al: B7-H3
silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3
phosphorylation. Mol Cancer Ther. 10:960–971. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Levy DE and Darnell JE Jr: Stats:
Transcriptional control and biological impact. Nat Rev Mol Cell
Biol. 3:651–662. 2002. View
Article : Google Scholar : PubMed/NCBI
|
24
|
Levy DE and Inghirami G: STAT3: A
multifaceted oncogene. Proc Natl Acad Sci USA. 103:10151–10152.
2006. View Article : Google Scholar : PubMed/NCBI
|
25
|
Schlessinger K and Levy DE: Malignant
transformation but not normal cell growth depends on signal
transducer and activator of transcription 3. Cancer Res.
65:5828–5834. 2005. View Article : Google Scholar : PubMed/NCBI
|